NCT02311881 - A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis | Biotech Hunter

Enrollment

960

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Pain

Interventions

DRUG

Paracetamol 1000 mg SR tablets

Two paracetamol 1000 mg SR tablets administered orally two times a day plus two placebo-matched paracetamol 665 mg SR tablets administered orally three times a day for 12 weeks.

DRUG

Paracetamol 665 mg SR tablets

Two paracetamol 665 mg SR tablets administered orally three times a day plus two placebo-matched paracetamol 1000 mg SR tablets administered orally two times a day for 12 weeks.

DRUG

Placebo

Two placebo-matched paracetamol 665 mg SR tablets administered orally three times a day plus two placebo-matched paracetamol 1000 mg SR tablets administered orally two times a day for 12 weeks.

Trial Locations (56)

11230

GSK Investigational Site, Brooklyn

14223

GSK Investigational Site, Buffalo

15478

GSK Investigational Site, Smithfield

16602

GSK Investigational Site, Altoona

16635

GSK Investigational Site, Duncansville

28601

GSK Investigational Site, Hickory

29464

GSK Investigational Site, Mt. Pleasant

31406

GSK Investigational Site, Savannah

32127

GSK Investigational Site, Port Orange

32132

GSK Investigational Site, Edgewater

32765

GSK Investigational Site, Oviedo

32806

GSK Investigational Site, Orlando

33012

GSK Investigational Site, Hialeah

33016

GSK Investigational Site, Hialeah

33030

GSK Investigational Site, Homestead

33143

GSK Investigational Site, South Miami

33155

GSK Investigational Site, Miami

33173

GSK Investigational Site, Miami

33185

GSK Investigational Site, Miami

33409

GSK Investigational Site, West Palm Beach

33458

GSK Investigational Site, Jupiter

33511

GSK Investigational Site, Brandon

33756

GSK Investigational Site, Clearwater

34677

GSK Investigational Site, Oldsmar

35242

GSK Investigational Site, Birmingham

35801

GSK Investigational Site, Huntsville

41017

GSK Investigational Site, Crestview Hills

43623

GSK Investigational Site, Toledo

45227

GSK Investigational Site, Cincinnati

45242

GSK Investigational Site, Cincinnati

45255

GSK Investigational Site, Cincinnati

45424

GSK Investigational Site, Dayton

60201

GSK Investigational Site, Evanston

60640

GSK Investigational Site, Chicago

63139

GSK Investigational Site, St Louis

66206

GSK Investigational Site, Prairie Village

67203

GSK Investigational Site, Wichita

68005

GSK Investigational Site, Bellevue

68134

GSK Investigational Site, Omaha

70115

GSK Investigational Site, New Orleans

73119

GSK Investigational Site, Oklahoma City

75075

GSK Investigational Site, Plano

75230

GSK Investigational Site, Dallas

78209

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

85224

GSK Investigational Site, Chandler

85712

GSK Investigational Site, Tucson

85745

GSK Investigational Site, Tucson

89119

GSK Investigational Site, Las Vegas

92103

GSK Investigational Site, San Diego

92801

GSK Investigational Site, Anaheim

93702

GSK Investigational Site, Fresno

95608

GSK Investigational Site, Carmichael

91606-1559

GSK Investigational Site, North Hollywood

02472

GSK Investigational Site, Watertown

Unknown

GSK Investigational Site, Hartsdale